BIT's 7th Annual International Congress of Antibodies-2015
About ICA - 2015

The Annual International Congress of Antibodies (ICA), initiated from 2009, had been successfully organized in Beijing, Hangzhou and Dalian, attracted more than 2,500 participants from 60 countries. ICA series congresses contribute to offering professionals in the field of antibody a multidisciplinary informative cooperative platform, and it has been the most definite and grand Antibody event in Asia. The ICA-2015, with the theme of ”Innovations from Defending Surface to Penetrating the Membrane” will be held on April 25-28, 2015 in Nanjing, China.

Nobel Laureates-2015

Dr. Bruce A. Beutler,
Professor, UT Southwestern,
USA

 

Nobel Prize laureate in Physiology or Medicine, 2011

Dr. Tim Hunt,
Emeritus Group Leader, Clare Hall Laboratories,
UK

 

Nobel Prize laureate in Physiology or Medicine, 2001
Program Layout
Sector 1: Main Conference
Part 1: Opening Ceremony and Keynote Forum Part 3: New Paradigm for International Collaboration on Antibody Development
Part 2: Global Antibody Economics and Market Trend Part 4: Antibody Safety, Quality Assurance, Policy and Regulatory Issues
Sector 2: Breaking Research of Antibodies
Track 1: Frontier of Antibody Research Track 3: Antibody Structure Prediction and Antibody Design
Track 2: Antibody Discovery and Technology Platforms  
Sector 3: Medical Applications of Antibodies, Antibody Engineering
Track 4: Antibody for Disease Diagnosis Track 8: Antibody-Mediated Drug Delivery System and Antibody Formulation
Track 5: Antibody-Drug Conjugates, Bispecific and Multispecific Antibodies Track 9: Antibody Engineering, Purification and Production
Track 6: Therapeutic Antibodies Track 10: Translational Medicine of Antibodies
Track 7: Antibody Biosimilars and Biobetters  
Sector 4: Non-medical Applications of Antibodies
Track 11: Antibodies in Food, Environmental and Agricultural Sciences Track 12: Antibodies in Food, Environmental and Agricultural Sciences
Sector 5: Parallel Scientific and Technological Conferences
BIT's 6th Annual World DNA & Genome Day 2015 BIT’s 4th Annual Conference and EXPO of AnalytiX 2015 (AnalytiX-2015)
BIT’s 6th Symposium of Enzyme &Biocatalysis (SEB-2015) BIT’s 7th Annual World Congress of Vaccines (WCV-2015)
BIT’s 5th World Congress of Molecular & Cell Biology (CMCB-2015) BIT’s 8th Annual World Protein and Peptide Conference (PepCon-2015)
BIT’s 8th World Congress of Industrial Biotechnology (IBIO-2015)  
Sector 6: Business and Career Development
Track 13: Antibody Business and Investment Track 14: Antibody Career Development
Sector 7: Posters and Exhibition
ICA-2015 will provide an ideal platform to showcase your new technologies and products in China. It is developed to maximize exposure of exhibitors, with coffee breaks and poster sessions for delegates taking place in the exhibition area.
  • Exposure Your New Products, Technology, Innovations and Latest Development to Visitors
  • Explore Business Opportunities in China and Beyond
  • Interaction with Visitors Face-to-Face, Exchanging Conversation and Sharing Information
  • Spotlight Your Technology and Its Commercial Application Promote Business
  • Take Advantage of the Targeted Audience at the Conference and Network in the Hall
  • Highlight your Impact and Influence
  • Increased Visibility and Name Recognition
  • Access to Competitive Intelligence
Sector 8: Social Events
Event 1: Culture Activities-Art Performance and Show
Event 2: Cocktail Social Networking
Event 3: City Tour As Requested
Event 4: Field Trip to Universities/Industries, and Networking Tour
Past Event Report

The 6th Annual International Congress of Antibodies 2014 (ICA-2014) has been held in Dalian International Conference Center from April 25-28 in Dalian, China. It was jointly held with the 5th Annual World DNA and Genome Day, the 7th Annual congress of Industrial Biotechnologh, the 7th Annual World Protein & Peptide Conference, the 6th Annual World congress of Vaccine, the 5th Symposium on Enzymes & Biocatalysis, the 4th Annual World congress of Molecular & Cell Biology, the 3rd Annual conference and EXPO of Analytix and the 5th Bio-Expo-2014, and has achieved great success, it is unprecedented grand.

This year’s conference has invited eleven Nobel masters and attracted more than 1500 participants from domestic and abroad. Many honored guests presented at the Nobel and keynote forum. In addition, there were 14 sessions following the Opening Ceremony covering 5 fields including Breaking Research on Antibody, Innovative Tech Platforms for Antibodies, Antibody Based Drug Discovery and Therapy-From Early to Late Stage, Antibodies in Medical Diagnosis, Antibody Engineering and Production.

After the conference many participants expressed their satisfaction with the content of the congress and had fine memories of Dalian. We believe that with the support and constructive suggestions from attendees, the next conference ICA-2015 will be even better.

Media

China Local Time
Days to Go!
News Release

Early bird registration for speech opportunity is open.
The scientific program is released.
• Call for speakers, exhibitors and sponsors worldwide.
• Call for media partners and advertiser worldwide.
Register now to enjoy favorable discount.

Call for papers

Hosting Organization

Information Research Center of International Talent, China State Administration of Foreign Experts Affairs, China

Supporting Organization

China Council for the Promotion of Intemational Trade, Nanjing Sub-Council

Official Travel Agency

BIT World Travel Service, Inc.

 

SkyTeam

Past Renowned Speakers
  Dr. Timothy Manser,
Professor & Chair, The Kimmel Cancer Center, USA
 
  Dr. Arvind Rajpal,
Senior Director, Rinat - Pfizer Inc., USA
 
  Dr. Mitchell Ho,
Head, NIH, USA
 
  Dr. Ralf Ostendorp,
Vice President, Protein Sciences, MorphoSys AG, Germany
 
  Dr. Jijie Gu,
Senior Principal Research Scientist, Global Biologics, AbbVie, USA
 
  Dr. Eva Kimby,
Professor, Karolinska University Hospital, Sweden
 
  Dr. Karlheinz Peter,
Professor, Monash University, Australia
 
  Dr. Yan Chen,
Senior Vice President, X-BODY BioSciences, USA
 
  Dr. Joe X Zhou,
CEO, Genor BioPharma Co. Ltd., China
 
  Dr. Carl K. Edwards,
President & CEO, Western States Biopharmaceuticals, Inc., USA
 
  Dr. T.-C. Wu,
Professor, The Johns Hopkins University School of Medicine, USA
 
  Dr. Zhengbin (Bing) Yao,
Sr. Vice President, MedImmune, USA
 
  Dr. Yajun Guo,
Professor, Second Military Medical University, China
 
  Dr. Robert Friesen,
VP, Antibody Discovery, Crucell NV, The Netherlands
 
  Dr. Igor A Kozlov,
Senior Director, Assay R&D, Prognosys Biosciences Inc., USA
 
  Dr. Titus Kretzschmar,
CSO, Delenex Therapeutics AG, Switzerland
 
  Dr. Peter A. Ward,
Professor, University of Michigan Medical School, USA
 
  Dr. Tim Pelura,
President & CEO, Immunome, Inc., USA
 
  Dr. Titan S. Fan,
President, Beacon Analytical Systems, Inc., USA
 
  Dr. Walter Bodmer,
Professor, University of Oxford, UK
 
  Dr. John Lowe,
Senior Director of Pathology, Genentech, Inc., USA
 
  Dr. David Wenyan Shen,
Executive Director and Head, Biologics Research & GlycoFi, Merck & Co., Inc., USA
 
  Dr. Anthony (Tony) Warford,
Discipline Leader, Histopathology, AstraZeneca, Innovation Center, China
 
  Dr. Frank Zhang,
CEO, GenScript Corporation, USA
 
  Dr. Zhi-Nan Chen,
Academician of Chinese Academy of Engineering, Professor, Fourth Military Medical University, China
 
  Sven Henrichwark,
General Manager, GE Healthcare Life Sciences, USA
 
  Dr. Andreas Baumann,
Principal Scientific Expert Biologics, Bayer Schering Pharma AG, Germany

Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.